Healthcare ETFs Have Good Prognosis
February 8th at 2:37pm by Tom Lydon
News that Pfizer was considering selling its consumer-products division in order to shore up shareholder value gave pharmaceutical stocks a boost on Wednesday.
Pharmaceutical HOLDRs (PPH) and iShares S&P Global Healthcare Sector (IXJ) are two ETFs where investors can make a diversified play in pharmaceutical stocks. In fact, Pfizer is the largest holding in each.
Technically speaking, now isn’t a bad time to consider these ETFs as both are just about to trade above their individual long-term trend lines (200-day moving average).
